Major health issue Dec18
PA Leads to Disease Dec18
Blood Test Dec18
Three or More Meds Dec18
Potassium Dec18
CT Scan Dec18
Sleep Apnea Dec18
Friends gathered in a coffee shop share their stories
Major-health-issue-Dec18
PA Leads to Disease-Dec18
Blood Test-Dec18
Three or More Meds-Dec18
Potassium-Dec18
CT Scan-Dec18
Sleep Apnea-Dec18
Patient-Stories-02282022
previous arrow
next arrow
Most Common Cause Mobile Dec18
PA Leads to disease mobile Dec18
Blood Draw ARR mobile Dec18
3 Medications mobile Dec18
Potassium Mobile Dec18
CT scan mobile Dec18
Sleep Apnea Mobile Dec19
Friends gathered to chat in a coffee house.
Most_Common_Cause_Mobile-Dec18
PA-Leads-to-disease-mobile-Dec18
Blood Draw ARR mobile-Dec18
3-Medications-mobile-Dec18
Potassium-Mobile-Dec18
CT scan mobile-Dec18
Sleep Apnea Mobile-Dec19
ShareYourStoryMobile-02282022
previous arrow
next arrow
Up to  0
people worldwide may have
primary aldosteronism
0
do not know
they do
0
could be
surgically cured
0
could be
medically treated

Although it affects millions of hypertensives, primary aldosteronism is mistakenly considered “rare.”
Understanding of the disease remains fragmented, and it is seldom diagnosed and treated.

Although it affects millions of hypertensives, primary aldosteronism is mistakenly considered “rare.” Understanding of the disease remains fragmented, and it is seldom adequately diagnosed and treated.

Welcome to the Primary Aldosteronism Foundation

A Non-Profit Committed to Advancing Standards of Care for all Affected Patients

We are a patient initiative created to make accurate and timely diagnosis and treatment a reality for all affected patients, foster targeted research and innovation, and facilitate patient collaboration worldwide.

Infographic

We help those who have, or suspect hyperaldosteronism, to navigate the road to accurate diagnosis, obtain adequate and effective treatment, stay abreast of relevant medical advances, and optimize their care.

We serve the primary aldosteronism community worldwide and are headquartered in the US state of Arizona.
Whether you or someone you know have high blood pressure that is long-standing and/or difficult to control, help us support the development of adequate responses to primary aldosteronism by signing the Foundation’s Open Letter.

We serve the primary aldosteronism community worldwide and are headquartered in the US state of Arizona.

Whether you or someone you know have hypertension that is long-standing and/or difficult to control, help us support the development of adequate responses to primary aldosteronism by signing the Foundation’s Open Letter.

Medical staff
Find a PA Expert
International specialists treating
primary aldosteronism.​
Medical Center Mayo Clinic
Find a Center of Excellence
Dedicated PA departments at
medical centers worldwide.
Social media
Find Support
Patient support groups and other resources available online.
Two hands joined and holding dirt and a tiny plant growing in it
It Takes a Village
Each contribution helps
to make a difference.
Translucid blue gell cap
Next-Generation PA Drugs
Clinical research studies are
recruiting PA participants.
Diverse pair of people standing beside each other
Patient Stories
Patients’ lived experience with
diagnosis and treatment